Shopping Cart
- Remove All
- Your shopping cart is currently empty
Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $210 | In Stock | |
5 mg | $497 | In Stock | |
10 mg | $678 | In Stock | |
25 mg | $953 | In Stock | |
50 mg | $1,180 | In Stock | |
100 mg | $1,500 | In Stock | |
200 mg | $1,960 | In Stock |
Description | Xinidamine (BRN 0891979) has antitumor activity and can be used to study benign prostatic hyperplasia, macular degeneration and prostatic intraepithelial neoplasia .Xinidamine inhibits the proliferation of PWR-1E cells with an IC50 of 4 μM. |
Targets&IC50 | Proliferation (PWR-1E cells):4 μM |
Alias | Xinidaminum, Xinidamino, BRN 0891979 |
Molecular Weight | 280.32 |
Formula | C17H16N2O2 |
Cas No. | 50264-78-3 |
Smiles | C(N1C=2C(C(C(O)=O)=N1)=CC=CC2)C3=C(C)C=C(C)C=C3 |
Relative Density. | 1.22g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (178.37 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.